For example, decreased proportions of CD4+ cells (T helper cells), CD4/CD8 ratios, and B cells and increased CD8+CD28- T lymphocytes and regulatory T (Treg) cells were observed in patients with lung cancer [10–13]. This evidence concerns the gene CD8A and lung carcinoma.